6.74 USD
▼+0.04-5.87%
盘后 7.23 +0.98%
2026-08-03
市值
$3.86M
市盈率
—
EPS
-98.07
股息率
—
52 周区间
2.98 – 80.10
成交量
17.03K
Beta
2.48
目标价
—
52W 低 2.9852W 高 80.10
价格走势
公司简介
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer’s disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral ta...